ISR’s latest Biologic API and Biologic Drug Product CDMO Benchmarking Reports have arrived Informing the pharmaceutical drug development, manufacturing and commercialization industry. Raleigh, NC – May 23, 2018 –Industry Standard Research’s (ISR’s) 3rd annual Biologic API Contract Manufacturer Quality Benchmarking…
Resources
Stay in the know with insight directly from industry experts and decision-makers
The 10th Edition of ISR’s Phase II/III CRO Benchmarking has arrived Informing pharmaceutical drug developers, manufacturers, and service providers. Raleigh, N.C. – May 17, 2018 – Industry Standard Research (ISR) has released a new report, the 10th edition of its…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 15, 2018 – Industry Standard Research’s (ISR’s) annual Small Molecule API Contract Manufacturer Quality Benchmarking report reveals that FLAMMA and Novasep received the highest Overall Performance Scores based…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – August 8, 2017 – Industry Standard Research’s (ISR’s) Small Molecule Sterile Injectable Drug Product Manufacturing Market Overview and Outlook report looks specifically at the portfolios and pipelines of small molecule sterile…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – July 25, 2017 – Industry Standard Research’s (ISR’s) Development vs Commercial Outsourced Manufacturing Practices: Small Molecule report offers insight into how the industry, using different outsourcing scenarios, prioritizes…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – July 25, 2017 – Industry Standard Research’s (ISR’s) Development vs Commercial Outsourced Manufacturing Practices: Biologics report offers insight into how respondents in different outsourcing scenarios prioritize different CMO selection…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC – May 31, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Oral Dosage Forms Market Overview and Outlook report offers details on how industry utilization rates of seventeen different…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC – May 31, 2017 – Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking – Phase IV Service Providers (9th Edition), containing findings focused on service provider…
The Phase I CROs received high marks in organization and staff factors Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC – May 18, 2017 – Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking – Phase I…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, N.C. – April 26, 2017 – Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking – Phase II/III Service Providers (9th Edition), containing findings focused on service…
Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – March 7, 2017 – Industry Standard Research (ISR) today announced the release of its latest CRO market report titled; 2017 Edition of the CRO Market Size Projections: 2016-2021….
Manufacturers benefit from having innovators as their parent companies Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 9, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Small Molecule API Contract Manufacturer Quality Benchmarking report…